KP Tissue Inc. (KPTSF) Stock Analysis

KP Tissue Inc. (KPTSF) Consumer Business Overview

KP Tissue Inc., operating through Kruger Products L.P., is a key player in the North American disposable tissue market. With a diverse brand portfolio and established distribution channels, the company caters to both consumer and commercial segments, navigating a competitive landscape with a focus on established brands and private label offerings.

What Is the Investment Thesis for KPTSF?

The company's consistent dividend yield of 6.64% offers an attractive income stream for investors. While the company's P/E ratio of 14.40 suggests a premium valuation, the low beta of 0.38 indicates lower volatility compared to the broader market. Growth catalysts include expansion within the Away-From-Home segment and potential for increased private label manufacturing. However, investors should be aware of risks associated with raw material price fluctuations and competitive pressures within the tissue market. The company's ability to maintain brand strength and optimize operational efficiency will be crucial for sustained profitability.

Based on FMP financials and quantitative analysis

KPTSF Key Highlights

Market capitalization of $92.9M indicates a small-cap company.

• P/E ratio of 14.40 reflects the company's earnings relative to its stock price.
• Beta of 0.38 suggests lower volatility compared to the overall market.
• Dividend yield of 6.64% provides a significant income stream for investors.
• Operates in the Consumer Defensive sector, which is generally considered stable during economic downturns.

Who Are KPTSF's Competitors?

KPTSF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are KPTSF's Key Strengths?

Strong brand recognition for key product lines.

• Established distribution network in North America.
• Diversified product portfolio catering to both consumer and commercial markets.
• Consistent dividend yield providing investor income.

What Are KPTSF's Weaknesses?

Reliance on Kruger Products L.P. for revenue generation.

• Exposure to fluctuations in raw material prices.
• Limited geographic diversification beyond North America.
• Small market capitalization compared to larger competitors.

What Could Drive KPTSF Stock Higher?

KPTSF catalyst: Expansion in the Away-From-Home segment, driven by increased demand for hygiene products in commercial settings.

• Focus on sustainable and eco-friendly products, attracting environmentally conscious consumers.
• Potential for new private label manufacturing contracts with major retailers.
• Product innovation and launch of new tissue products with enhanced features.
• Consistent dividend yield providing an attractive income stream for investors.

What Are the Key Risks for KPTSF?

Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.

• Intense competition from larger players in the tissue market, potentially impacting market share and profitability.
• Fluctuations in raw material prices, such as pulp and paper, affecting production costs and margins.
• Economic downturns impacting consumer spending on non-essential household products.
• Changes in consumer preferences and demand for sustainable products, requiring adaptation and investment.
• Risks associated with operating in the OTC market, including limited liquidity and regulatory oversight.

What Are the Growth Opportunities for KPTSF?

• Expansion in the Away-From-Home Segment: The Away-From-Home segment presents a significant growth opportunity for KP Tissue. As businesses and public facilities increasingly focus on hygiene and cleanliness, the demand for disposable tissue products in this segment is expected to rise. By strengthening its distribution network and tailoring its product offerings to meet the specific needs of commercial users, KP Tissue can capture a larger share of this growing market. The global away-from-home tissue market is projected to reach $30 billion by 2028.
• Increased Private Label Manufacturing: KP Tissue can leverage its manufacturing capabilities to expand its private label business. Retailers are increasingly seeking private label partnerships to offer cost-effective alternatives to branded products. By offering competitive pricing and high-quality products, KP Tissue can attract new private label contracts and increase its overall production volume. This strategy can also help the company diversify its revenue streams and reduce its reliance on branded product sales. The private label market is estimated to be around $200 billion.
• Product Innovation and Differentiation: Investing in product innovation and differentiation is crucial for KP Tissue to maintain its competitive edge. Developing new tissue products with enhanced features, such as increased absorbency, softness, or eco-friendliness, can attract new customers and retain existing ones. The company can also explore innovative packaging solutions and marketing campaigns to differentiate its products from competitors. Ongoing research and development efforts are essential for staying ahead of market trends and meeting evolving consumer needs. The tissue market sees hundreds of new product launches every year.
• Geographic Expansion within North America: While KP Tissue already has a presence in Canada and the United States, there is potential for further geographic expansion within these markets. Identifying underserved regions or demographic segments and tailoring its product offerings to meet their specific needs can drive sales growth. The company can also explore strategic partnerships with local distributors to expand its reach and market penetration. Market research and analysis are essential for identifying promising geographic expansion opportunities.
• Focus on Sustainable and Eco-Friendly Products: With growing consumer awareness of environmental issues, there is increasing demand for sustainable and eco-friendly tissue products. KP Tissue can capitalize on this trend by investing in sustainable sourcing practices, reducing its environmental footprint, and developing eco-friendly products. This can enhance the company's brand image, attract environmentally conscious consumers, and gain a competitive advantage in the market. The global market for sustainable paper products is projected to reach $40 billion by 2027.

What Are KPTSF's Competitive Advantages?

• Established brand portfolio with well-known brands like Cashmere, Purex, and SpongeTowels.
• Extensive distribution network across Canada and the United States.
• Manufacturing capabilities for both branded and private label products.
• Long-standing relationships with retailers and distributors.

What Does KPTSF Do?

KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada. The company's primary asset is its investment in Kruger Products L.P., a leading manufacturer and distributor of disposable tissue products. Kruger Products L.P. traces its roots back to the early 20th century, evolving from a pulp and paper business into a consumer-focused tissue product company. KP Tissue operates through two segments: Consumer and Away-From-Home. The Consumer segment focuses on retail channels, offering products like bathroom tissue, facial tissue, paper towels, and napkins under well-known brands such as Cashmere, Purex, SpongeTowels, and Scotties. The Away-From-Home segment caters to commercial users, including property management, healthcare, food services, manufacturing, lodging industries, and public facilities, providing tissue products through distributors. The company also manufactures private label tissue products for various retailers. KP Tissue distributes its products through traditional retail channels, including grocery stores, mass merchandisers, club and drug stores, convenience stores, and online retailers. The company's geographic focus is primarily Canada and the United States.

What Products and Services Does KPTSF Offer?

• Produces bathroom tissue for consumer use.
• Manufactures facial tissues for various needs.
• Creates paper towels for household and commercial cleaning.
• Offers napkins for both consumer and away-from-home markets.
• Manufactures private label tissue products for retailers.
• Distributes tissue products through retail channels.
• Supplies tissue products to commercial users through distributors.

How Does KPTSF Make Money?

• Manufactures and sells disposable tissue products.
• Generates revenue through sales to consumers via retail channels.
• Generates revenue through sales to commercial users via distributors.
• Offers private label manufacturing services to retailers.

What Industry Does KPTSF Operate In?

KP Tissue Inc. operates within the competitive household and personal products industry, specifically focusing on the disposable tissue segment. The market is characterized by stable demand, driven by essential consumer needs. Key trends include a growing emphasis on sustainable and eco-friendly products, as well as increasing demand for private label brands. The company competes with larger players like CHFHY (Cascades Inc.), CHUC (Church & Dwight Co.), HWIN (Howe Sound Pulp and Paper Limited), MJWNY (Mcj Paper), and NWINF (Northwest Innovation Works Inc.) who have significant market share and brand recognition. KP Tissue's success depends on its ability to maintain brand loyalty, innovate with new products, and efficiently manage its supply chain.

Who Are KPTSF's Key Customers?

• Consumers purchasing tissue products for household use.
• Businesses and organizations in the property management, healthcare, food services, manufacturing, and lodging industries.
• Retailers seeking private label tissue products.

Company Profile

KP Tissue Inc. operates in the Household & Personal Products industry within the Consumer Defensive sector. It is headquartered in Mississauga, CA. The company is led by CEO Dino J. Bianco. KPTSF has traded publicly since 2015.

Return on equity for KP Tissue Inc. stands at 12.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 12.3%, showing how much profit it generates from its asset base. KPTSF trades at a trailing price-to-earnings ratio of 14.40, below the Consumer Defensive sector average of ~27.60x. A current ratio of 1.00 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.7%, the inverse of the P/E and a quick read on earnings relative to price.

KPTSF Valuation & Market Position

With a $92.9M market cap, KP Tissue Inc. sits in the micro-cap segment of the market.

Quarterly Financial Performance: KP Tissue Inc.

Revenue for KP Tissue Inc. came in at $0 during Q2 FY2026. The company recorded net income of $1.8M, with diluted EPS of $0.17. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Consumer Defensive. Across the four most recent quarters, KPTSF averaged $0.16 in diluted EPS.

KP Tissue Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 34.45 places it in the safe zone, indicating low near-term bankruptcy risk.

KP Tissue Inc. has beaten Wall Street's EPS estimate in 6 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 82.7% above estimates on average.

KPTSF Financials

KPTSF Latest News

KPTSF Analyst Consensus

KPTSF MoonshotScore

Common Questions About KPTSF (Consumer Defensive)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources